Precedent Wealth Partners’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
15,597
+3,250
+26% +$306K 0.19% 110
2026
Q1
$1.46M Buy
12,347
+2,555
+26% +$316K 0.29% 98
2025
Q4
$1.23M Buy
9,792
+432
+5% +$56.3K 0.26% 103
2025
Q3
$1.37M Buy
9,360
+1,403
+18% +$212K 0.3% 97
2025
Q2
$1.24M Buy
7,957
+1,309
+20% +$208K 0.3% 97
2025
Q1
$1.09M Buy
6,648
+1,673
+34% +$278K 0.3% 91
2024
Q4
$811K Buy
4,975
+210
+4% +$37.6K 0.26% 98
2024
Q3
$931K Buy
4,765
+807
+20% +$149K 0.31% 86
2024
Q2
$686K Buy
3,958
+674
+21% +$112K 0.28% 83
2024
Q1
$556K Buy
+3,284
New +$615K 0.24% 93

Other funds holding ZTS

Precedent Wealth Partners's ZTS Position: Q2 2026 in Review

Precedent Wealth Partners increased its Zoetis (ZTS) stake by 26% in Q2 2026, buying an estimated $306K and bringing the position to 15,597 shares worth $1.12M. The position accounts for 0.19% of the portfolio, ranked #110.

Precedent Wealth Partners first reported a position in ZTS in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.46M in Q1 2026. 1,429 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Precedent Wealth Partners held 15,597 shares of Zoetis worth $1.12M as of Q2 2026.
  • Precedent Wealth Partners bought 3,250 Zoetis shares in Q2 2026, an estimated $306K.
  • Zoetis made up 0.19% of Precedent Wealth Partners's portfolio in Q2 2026, its #110 holding.
  • Precedent Wealth Partners first reported a position in Zoetis in Q1 2024 and has held it in 10 quarters since.
  • Precedent Wealth Partners's Zoetis position peaked at $1.46M in Q1 2026.
  • 1,429 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Precedent Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.